Andrew Lu

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Andrew Lu

Andrew Lu is recorded as Analyst at Jefferies. Andrew Lu has spoken on 3 earnings calls and 1 other investor event across 4 companies, most recently for Energy Transfer LP on August 4, 2026. Those appearances were for Energy Transfer LP (ET), Rocket Pharmaceuticals, Inc. (RCKT), Iovance Biotherapeutics, Inc. (IOVA) and Berkley W R Corp (WRB). The companies whose calls Andrew Lu spoke on are classified in the Energy, Healthcare and Financial Services sectors.

Andrew Lu on recent calls

“One, with the data center interest that we're seeing kind of in the Texas DFW corridor region, and also with the potential grid interconnection delays that we're also seeing really as recent this last week with the legislative hearings.”

Analyst — Jefferies, Energy Transfer LP Q2 FY2026 Earnings Call · August 4, 2026

“Big congratulations on the execution and approval. It's exciting times. So you're planning to launch in Q4. Maybe describe the gating steps you need to accomplish or address before you're ready to launch.”

Analyst — Jefferies, KRESLADI™ FDA Approval Investor Conference Call · March 27, 2026

“So if the guidance for net cash burn is going to be less than 235 over the next year, and I believe restructuring happens later in the year, it feels as if you're expecting gross margins to improve meaningfully, maybe even as early as Q3 relative to Q2 and Q1.”

Analyst — Jefferies, Iovance Biotherapeutics, Inc. Q2 FY2025 Earnings Call · August 7, 2025

“I was just hoping within insurance in short tail lines some pretty good growth this year and particularly in the quarter can you almost just think about the drivers there was it property inland marine a and h yes yes yes and yes okay so kind of all three contributing property and inland marine uh though it's not as…”

Analyst — Jefferies, Berkley W R Corp Q4 FY2024 Earnings Call · January 27, 2025